- Home
- SFHG vs PRQR Comparison
SFHG vs PRQR Comparison
Compare SFHG & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SFHG | PRQR |
|---|---|---|
| Founded | 1993 | 2012 |
| Country | Hong Kong | Netherlands |
| Employees | N/A | N/A |
| Industry | Publishing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6M | 250.7M |
| IPO Year | 2024 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SFHG | PRQR |
|---|---|---|
| Price | $0.87 | $1.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $8.14 |
| AVG Volume (30 Days) | 162.1K | ★ 658.1K |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $19,577,200.00 | $18,859,556.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $19.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.56 | N/A |
| 52 Week Low | $0.32 | $1.07 |
| 52 Week High | $2.32 | $3.10 |
Technical Indicators
Market Signals| Indicator | SFHG | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 64.51 | 40.51 |
| Support Level | $0.75 | $2.03 |
| Resistance Level | $0.98 | $2.31 |
| Average True Range (ATR) | 0.08 | 0.17 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 72.64 | 13.04 |
Price Performance
Historical ComparisonAbout SFHG Samfine Creation Holdings Group Limited Ordinary Share
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.